RxDoctor Payments Data

Theresa Hohertz

Nurse Practitioner · Des Moines, IANPI 1093944514

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (40.6%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Myriad Genetic Laboratories, Inc. at 44.5% of the total. Reporting peaked in 2023 at $3,654 and has fallen 83.6% since, to $599 in 2025. Among nurse practitioner clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,361in general payments, 2019–2025

Across 77 payments — averaging $108.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Myriad Genetic Laboratories, Inc.$4K
  • Immunogen, Inc.$2K
  • GSK$503
  • AbbVie$381
  • Merck$215
  • Novo Nordisk$161
  • plus $1K from 14 others

What the payments were for

  • Consulting fees$1,81922%
  • Speaking & faculty fees$1,97524%
  • Travel & lodging$1,16314%
  • Food & beverage$3,39541%
  • Education$110%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,361 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in Iowa.

See all nurse practitioner providers in Iowa

Other nurse practitioner in Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →